OBJECTIVE: To identify the prevalence of disability in a wide range of valued life activities (VLAs) among individuals with systemic lupus erythematosus (SLE), 1-year changes in such disability, and predictors of and changes in VLA disability. METHODS: Data were from 2 waves of a cohort of 829 individuals with SLE interviewed annually by telephone. VLA disability was assessed using a scale rating the difficulty of performing 21 activities. Scores were also calculated for subscales corresponding to obligatory, committed, and discretionary activities. Changes in VLA disability from baseline to 1-year followup were assessed. Sociodemographic and disease status measures were examined as predictors of and changes in VLA disability using multiple regression analyses. RESULTS: Almost half of the subjects were unable to perform > or =1 VLA at baseline. Almost all (91%) reported > or =1 VLA affected by SLE. One-quarter of the subjects experienced a significant increase in the number of activities they were unable to perform; approximately half experienced significant increases in the number of activities affected and in difficulty scores. Proportions of individuals whose disability increased and whose disability decreased were roughly equivalent. Disease status measures accounted for 62-72% of the variation in VLA difficulty. More severe disease status was predictive of increases in VLA difficulty; few predictors of improvements were identified. CONCLUSION: VLA disability was common, with more disability noted in committed and discretionary activities than in obligatory activities. Because VLA disability has been linked to psychological well-being in previous studies, identification of factors that may protect against such disability is important.
OBJECTIVE: To identify the prevalence of disability in a wide range of valued life activities (VLAs) among individuals with systemic lupus erythematosus (SLE), 1-year changes in such disability, and predictors of and changes in VLA disability. METHODS: Data were from 2 waves of a cohort of 829 individuals with SLE interviewed annually by telephone. VLA disability was assessed using a scale rating the difficulty of performing 21 activities. Scores were also calculated for subscales corresponding to obligatory, committed, and discretionary activities. Changes in VLA disability from baseline to 1-year followup were assessed. Sociodemographic and disease status measures were examined as predictors of and changes in VLA disability using multiple regression analyses. RESULTS: Almost half of the subjects were unable to perform > or =1 VLA at baseline. Almost all (91%) reported > or =1 VLA affected by SLE. One-quarter of the subjects experienced a significant increase in the number of activities they were unable to perform; approximately half experienced significant increases in the number of activities affected and in difficulty scores. Proportions of individuals whose disability increased and whose disability decreased were roughly equivalent. Disease status measures accounted for 62-72% of the variation in VLA difficulty. More severe disease status was predictive of increases in VLA difficulty; few predictors of improvements were identified. CONCLUSION: VLA disability was common, with more disability noted in committed and discretionary activities than in obligatory activities. Because VLA disability has been linked to psychological well-being in previous studies, identification of factors that may protect against such disability is important.
Authors: A J Partridge; E W Karlson; L H Daltroy; R A Lew; E A Wright; A H Fossel; K V Straaton; S H Stern; A F Kavanaugh; W N Roberts; M H Liang Journal: Arthritis Rheum Date: 1997-12
Authors: E W Karlson; L H Daltroy; R A Lew; E A Wright; A J Partridge; A H Fossel; W N Roberts; S H Stern; K V Straaton; M C Wacholtz; A F Kavanaugh; J M Grosflam; M H Liang Journal: Arthritis Rheum Date: 1997-01
Authors: E W Karlson; L H Daltroy; R A Lew; E A Wright; A J Partridge; W N Roberts; S H Stern; K V Straaton; M C Wacholtz; J M Grosflam Journal: Arthritis Rheum Date: 1995-02
Authors: Patricia Katz; Jinoos Yazdany; Laura Julian; Laura Trupin; Mary Margaretten; Edward Yelin; Lindsey A Criswell Journal: Arthritis Care Res (Hoboken) Date: 2011-10 Impact factor: 4.794
Authors: James S Andrews; Laura Trupin; Gabriela Schmajuk; Jennifer Barton; Mary Margaretten; Jinoos Yazdany; Edward H Yelin; Patricia P Katz Journal: Arthritis Care Res (Hoboken) Date: 2015-08 Impact factor: 4.794
Authors: James S Andrews; Laura Trupin; Gabriela Schmajuk; Jennifer Barton; Mary Margaretten; Jinoos Yazdany; Edward H Yelin; Patricia P Katz Journal: Arthritis Care Res (Hoboken) Date: 2015-01 Impact factor: 4.794
Authors: Nikolas H Kazmers; Man Hung; Jerry Bounsanga; Maren W Voss; Abby Howenstein; Andrew R Tyser Journal: J Hand Surg Am Date: 2019-05-06 Impact factor: 2.230
Authors: Patricia P Katz; Diane C Radvanski; Diane Allen; Steven Buyske; Samuel Schiff; Anagha Nadkarni; Lisa Rosenblatt; Ross Maclean; Afton L Hassett Journal: Arthritis Care Res (Hoboken) Date: 2011-12 Impact factor: 4.794
Authors: James S Andrews; Laura Trupin; Edward H Yelin; Catherine L Hough; Kenneth E Covinsky; Patricia P Katz Journal: Clin Rheumatol Date: 2017-01-23 Impact factor: 2.980
Authors: Patricia P Katz; Steven Gregorich; Mark Eisner; Laura Julian; Hubert Chen; Edward Yelin; Paul D Blanc Journal: J Cardiopulm Rehabil Prev Date: 2010 Mar-Apr Impact factor: 2.081